Concepedia

Claire C. J. Dekkers

CC

Statistics

Publications

7

Citations

880

H-Index

7

Active since

2017

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Ziekenhuis Groep Twente

AstraZeneca (Sweden)

University of Toronto

Claire C. J. Dekkers is an author at University Medical Center Groningen specializing in pharmacotherapy, pharmacology, and renal disease.

ORCID

Publications per year

2017–2022

7

Publications

7

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour et al. · The Lancet Diabetes & Endocrinology · 2020 · 274 citations · Full text

, , +11

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers

Claire C. J. Dekkers, S. Petrykiv, Gozewijn D. Laverman et al. · Diabetes Obesity and Metabolism · 2018 · 258 citations · Full text

, , +17

Effects of the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes

Claire C. J. Dekkers, C. David Sjöström, Peter J. Greasley et al. · Diabetes Obesity and Metabolism · 2019 · 106 citations · Full text

, , +16

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease

Claire C. J. Dekkers, David C. Wheeler, C. David Sjöström et al. · Nephrology Dialysis Transplantation · 2017 · 102 citations · Full text

, , +17

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Mie K. Eickhoff, Claire C. J. Dekkers, Bart J. Kramers et al. · Journal of Clinical Medicine · 2019 · 93 citations · Full text

, , +17

1–5 of 7